Edition:
India

Keryx Biopharmaceuticals Inc (KERX.OQ)

KERX.OQ on NASDAQ Stock Exchange Capital Market

4.84USD
10:12pm IST
Change (% chg)

$-0.14 (-2.91%)
Prev Close
$4.99
Open
$5.00
Day's High
$5.04
Day's Low
$4.84
Volume
73,813
Avg. Vol
433,916
52-wk High
$8.37
52-wk Low
$4.33

Select another date:

Thu, Dec 28 2017

BRIEF-Keryx Biopharma Says Norwich Pharmaceuticals Agreed To Terminate Manufacturing Services Agreement

* KERYX BIOPHARMACEUTICALS- ON DEC 20,CO,NORWICH PHARMACEUTICALS AGREED TO TERMINATE MANUFACTURING SERVICES AGREEMENT BETWEEN CO,NPI,DATED JAN 17, 2014‍​

BRIEF-Biovectra And Keryx Biopharmaceuticals Enter Agreement For Ferric Citrate Production Expansion

* BIOVECTRA AND KERYX BIOPHARMACEUTICALS ENTER AGREEMENT FOR FERRIC CITRATE PRODUCTION EXPANSION

BRIEF-Keryx Biopharmaceuticals Q3 loss per share $0.20

* Keryx Biopharmaceuticals announces third quarter 2017 financial results

BRIEF-KERYX BIOPHARMACEUTICALS SAYS MICHAEL ROGERS APPOINTED CHAIRMAN OF BOARD

* KERYX BIOPHARMACEUTICALS ANNOUNCES CHANGES TO ITS BOARD OF DIRECTORS

BRIEF-Keryx Biopharmaceuticals Inc - co and Patheon Inc entered into a product agreement - SEC filing​

* Keryx Biopharmaceuticals Inc - co and Patheon Inc entered into a product agreement - SEC filing​

BRIEF-Keryx Biopharmaceuticals Q2 loss per share $0.77

* Keryx Biopharmaceuticals announces second quarter 2017 financial results and increased 2017 u.s. Product sales guidance

Select another date: